FDA Drug recall D-258-2013
Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60…
- FDA Drug
- Class II
- completed
- Published 2013-04-24
On 2013-04-24 the FDA classified a Class II recall of Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60… by Pfizer, citing chemical contamination: emission of strong odor after package was opened.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-258-2013 |
| Classification | Class II |
| Status | completed |
| Initiated | 2013-03-28 |
| Published | 2013-04-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pfizer |
| Distribution | US |
Product
Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60793-857-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
Reason
Chemical contamination: emission of strong odor after package was opened.
Identifiers
| ndc | 60793-850-10 |
|---|---|
| ndc | 60793-850-01 |
| ndc | 60793-851-10 |
| ndc | 60793-851-01 |
| ndc | 60793-852-10 |
| ndc | 60793-852-01 |
| ndc | 60793-853-10 |
| ndc | 60793-853-01 |
| ndc | 60793-854-10 |
| ndc | 60793-854-01 |
| ndc | 60793-855-10 |
| ndc | 60793-855-01 |
| ndc | 60793-856-10 |
| ndc | 60793-856-01 |
| ndc | 60793-857-10 |
| ndc | 60793-857-01 |
| ndc | 60793-858-10 |
| ndc | 60793-858-01 |
| ndc | 60793-859-10 |
| ndc | 60793-859-01 |
| ndc | 60793-860-10 |
| ndc | 60793-860-01 |
| code_info | Lot # a) 67013B, Exp. 01/14; b) 66900B, Exp. 01/14 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-258-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.